作者: Eleni Liapi , Jean-Francois H. Geschwind
DOI: 10.1245/S10434-010-0977-4
关键词: Medicine 、 Oncology 、 Surgical oncology 、 Chemotherapy 、 Internal medicine 、 Radiology 、 Arterial Embolization 、 Clinical trial 、 Hepatocellular carcinoma 、 Evidence-based medicine 、 Lipiodol 、 Radiation therapy
摘要: Abstract Purpose and Design Intra-arterial therapies for unresectable hepatocellular carcinoma (HCC) consist of a catheter-based group of treatments where therapeutic and/or embolic agents are intra-arterially directed to target tumors. Here we review these therapies, which may be classified into embolotherapy/chemotherapy-based and radiotherapy-based treatments. Embolotherapy/chemotherapy-based treatments include transcatheter arterial embolization, transarterial chemoembolization, transcatheter arterial chemoeinfusion, and …